Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
Public ClinicalTrials.gov record NCT01313208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the effectiveness of adding etanercept to disease modifying anti-rheumatic drug (DMARD) therapy in patients with moderately active Rheumatoid Arthritis (RA).
Study identification
- NCT ID
- NCT01313208
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2011 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- May 2013 (Actual)
- Last update posted
- Feb 9, 2017
2011 – 2013
United States locations
- U.S. sites
- 38
- U.S. states
- 20
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Encino | California | 91436 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | Inglewood | California | 90301 | — |
| Research Site | La Jolla | California | 92037 | — |
| Research Site | Murrieta | California | 92563 | — |
| Research Site | Santa Maria | California | 93454 | — |
| Research Site | Tustin | California | 92780 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Victorville | California | 92395 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Jacksonville | Florida | 32209 | — |
| Research Site | Ocala | Florida | 34474 | — |
| Research Site | Sarasota | Florida | 34239 | — |
| Research Site | Sebring | Florida | 33870 | — |
| Research Site | Tampa | Florida | 33613 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Meridian | Idaho | 83642 | — |
| Research Site | Springfield | Illinois | 62704 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Frederick | Maryland | 21702 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Saint Clair Shores | Michigan | 48081 | — |
| Research Site | Bismarck | North Dakota | 58501 | — |
| Research Site | Akron | Ohio | 44311 | — |
| Research Site | Mayfield Village | Ohio | 44143 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Oklahoma City | Oklahoma | 73109 | — |
| Research Site | Portland | Oregon | 97239 | — |
| Research Site | Erie | Pennsylvania | 16508 | — |
| Research Site | Greer | South Carolina | 29650 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78232 | — |
| Research Site | Chesapeake | Virginia | 23320 | — |
| Research Site | Seattle | Washington | 98133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01313208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01313208 live on ClinicalTrials.gov.